Pembrolizumab on pre-existing inclusion body myositis: a case report

BACKGROUND: Cases of exacerbation of pre-existing neuromuscular diseases induced by immune checkpoint inhibitors (ICIs) have rarely been reported because patients with autoimmune diseases have generally been excluded from ICI therapy due to the increased risk of exacerbation. We describe the first c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Rheumatol
Autors principals: Uchio, Naohiro, Unuma, Atsushi, Kakumoto, Toshiyuki, Osaki, Masao, Zenke, Yoshitaka, Sakuta, Kenichi, Kubota, Akatsuki, Uesaka, Yoshikazu, Toda, Tatsushi, Shimizu, Jun
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7493364/
https://ncbi.nlm.nih.gov/pubmed/32944686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41927-020-00144-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars